{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 50.18,
  "market_cap": 222973804544,
  "revenue_ttm": 49586780754.981415,
  "net_income_ttm": 16304563008.864574,
  "ocf_ttm": 19448642975.429955,
  "capex_ttm": 9872326251.520113,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1395047025.2927887,
  "total_debt": 15902499112.285652,
  "cash_and_equivalents": 5119362228.304419,
  "book_value_ttm": 26693648993.03341,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4670882,
  "dividend_yield": 344.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-15T06:34:25Z"
}